Hyperpigmentation due to topical application of silver sulfadiazine cream.
D000287:Administration, Topical; D002675:Child, Preschool; D005260:Female; D006801:Humans; D010859:Pigmentation Disorders / Q000139:chemically induced* / Q000473:pathology; D012837:Silver Sulfadiazine / Q000008:administration & dosage / Q000009:adverse effects*; D012867:Skin / Q000473:pathology; D013411:Sulfadiazine / Q000009:adverse effects*
D013411:Sulfadiazine; D012837:Silver Sulfadiazine